Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
Clinical trial NCT03894891 · COMPLETED
Trial details
- NCT number
- NCT03894891
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-11
- Primary completion
- 2022-10-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.